Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult Subjects

Trial Identifier: PT010010
Sponsor:Pearl Therapeutics, Inc.
Start Date:April 2017
Primary Completion Date: September 2017
Study Completion Date: September 2017
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

English Translation
Chinese Translation

Trial Locations

China Shanghai, China, 200031